Background Brain metastases (BM) in patients with advanced and metastatic non-small cell
lung cancer (NSCLC) are linked with poor prognosis. Identifying genomic alterations …

Brain metastases (BMs) are the most common form of intracranial malignant neoplasms in
adults, with a profound impact on quality of life and traditionally associated with a dismal …

Objectives Thoracic radiation therapy (TRT) and prophylactic cranial irradiation (PCI) are
commonly used in the management of extensive-stage small-cell lung cancer (ES-SCLC); …

Background and objective Epidermal growth factor receptor (EGFR)–targeted tyrosine
kinase inhibitors (TKIs) are the first-line therapy for EGFR-mutant non-small-cell lung cancer …

Background: Limited data exist on the impact of immunotherapy use in ethnic minority
patients with non–small cell lung cancer (NSCLC), because they have been …

Purpose Cognitive impairment is common in lung cancer patients and impacts their quality
of life. Little is known about the etiology of cognitive impairment in lung cancer patients …

The prognosis for patients with non‑small cell lung cancer (NSCLC), a cancer type which
represents 85% of all lung cancers, is poor with a 5‑year survival rate of 19%, mainly …

In single-fraction (sf) stereotactic radiosurgery (SRS) for brain metastases (BM) from lung
adenocarcinoma (LAC), a marginal dose of≥ 22-24 Gy is generally deemed desirable for …

Most parotid metastases have been reported to come from the head and neck; however,
cases metastasized from the lung are extremely rare. Missed diagnoses and misdiagnoses …

Introduction Sarcomas, a group of neoplasms comprising both tissue and bone soft tissue
tumors, has an increasing prevalence in recent years. Prognosis significantly hinges on …